• KP Tissue’s Q3 2026 net income doubled year-over-year to CAD 3.1 million.
• Kruger Products’ revenue rose 5% to CAD 589.7 million, primarily due to higher Consumer volumes and favorable U.S. Consumer pricing.
• The new TAD facility will not begin operations in 2028, with its location decision deferred pending greater economic and trade certainty.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KP Tissue Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611110700NEWSFILECNPR____20261111_322858_1) on November 11, 2026, and is solely responsible for the information contained therein.